ash road north, ipsen, p planning documents

The 120,000 sq ft manufacturing facility will accompany Ipsen's existing warehouse. Credit: via planning documents

Global biopharmaceutical manufacturer eyes Wrexham base expansion

Ipsen BioPharm has submitted plans to build a 120,000 sq ft manufacturing facility next to its existing warehouses off Ash Road North on the city’s industrial estate.

Part of the Ipsen Group, the global manufacturer wants to expand its existing Wrexham base where it develops products that provide unique therapeutic indications for severe diseases.

Designed by Lovelock Mitchell Architects, the scheme would deliver a three-storey manufacturing facility featuring open-plan offices, a large plant room, and air-handling units.

Ipsen owns the vacant site, which was previously occupied by a large warehouse and despatch building before it was demolished in 2019.

Proposals also include the provision of 24 car parking spaces dedicated to the new building, in addition to the 264 existing spaces used by Ipsen staff across the whole estate.

Ipsen has been based at the Wrexham site since 1995 and currently employs more than 400 people there, making it the city’s third biggest employer.

If these plans are approved, the new warehouse will accommodate an additional 24 new staff.

The company occupies 53 locations across the world, with another two UK bases in Oxford and Slough.

ash road north existing, ipsen, p planning documents

Ipsen has been based on the site since 1995. Credit: via planning documents

The project team includes Axis Transport Services, Land Studio, Cambrian Ecology, and Envirocheck.

To learn more about the plans, search for application number P/2023/0482 on Wrexham Council’s planning portal.

Your Comments

Read our comments policy

Related Articles

Sign up to receive the Place Daily Briefing

Join more than 13,000 property professionals and receive your free daily round-up of built environment news direct to your inbox


Join more than 13,000 property professionals and sign up to receive your free daily round-up of built environment news direct to your inbox.

By subscribing, you are agreeing to our Terms & Conditions and Privacy Policy.